Vivesto
A specialty pharmaceutical company developing oncology drugs for hard-to-treat cancers.
VIVE | ST
Overview
Corporate Details
- ISIN(s):
- SE0000722365 (+4 more)
- LEI:
- 5493003TZPR4B7QO9L49
- Country:
- Sweden
- Address:
- Box 3061, 169 03 SOLNA
- Website:
- https://www.vivesto.com/en/
- Sector:
- Manufacturing
Description
Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-20 08:35 |
Notice of Extraordinary General Meeting in Vivesto AB
|
English | 85.0 KB | ||
| 2025-11-20 08:35 |
Kallelse till extra bolagsstämma i Vivesto AB
|
Swedish | 83.6 KB | ||
| 2025-11-20 08:30 |
Vivesto resolves on a fully secured rights issue of approximately SEK 53.8 mill…
|
English | 90.9 KB | ||
| 2025-11-20 08:30 |
Vivesto beslutar om en fullt säkerställd företrädesemission om cirka 53,8 MSEK …
|
Swedish | 90.3 KB | ||
| 2025-11-20 08:00 | Swedish | 773.7 KB | |||
| 2025-11-07 15:15 |
Vivesto rapporterar positiva interimsresultat från pilotstudie med Paccal Vet i…
|
Swedish | 64.3 KB | ||
| 2025-11-07 15:15 |
Vivesto reports positive interim results for Paccal Vet pilot study in dogs
|
English | 63.6 KB | ||
| 2025-11-07 10:00 |
Valberedning utsedd inför Vivestos årsstämma 2026
|
Swedish | 50.2 KB | ||
| 2025-11-07 10:00 |
Nomination Committee appointed for the Annual General Meeting 2026 in Vivesto
|
English | 50.6 KB | ||
| 2025-08-12 08:00 | Swedish | 640.9 KB | |||
| 2025-05-08 10:30 |
Kommuniké från årsstämma i Vivesto AB
|
Swedish | 54.9 KB | ||
| 2025-05-08 10:30 |
Report from Annual General Meeting in Vivesto AB
|
English | 54.6 KB | ||
| 2025-05-08 08:00 | Swedish | 612.7 KB | |||
| 2025-04-08 08:05 | Swedish | 16.3 MB | |||
| 2025-04-08 08:00 |
Notice of Annual General Meeting in Vivesto AB
|
English | 78.4 KB |
Automate Your Workflow. Get a real-time feed of all Vivesto filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vivesto
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vivesto via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-08-19 | Anders Härfstrand | Other | Buy | 20,000 | 53,132.58 SEK |
| 2021-07-16 | Peter Zonabend | Other | Buy | 100,000 | 302,623.60 SEK |
| 2021-07-14 | Fredrik Järrsten | Other | Buy | 20,000 | 58,200.00 SEK |
| 2021-07-13 | Francois-Regis Martelet | Other | Buy | 41,000 | 121,370.00 SEK |
| 2021-07-08 | Birgit Agneta Stattin Norinder | Other | Buy | 35,000 | 104,480.00 SEK |
| 2021-07-06 | Anders Härfstrand | Other | Buy | 100,000 | 285,653.00 SEK |
| 2020-10-13 | Francois-Regis Martelet | Other | Buy | 20,000 | 85,000.00 SEK |
| 2020-10-12 | Anders Härfstrand | Other | Buy | 30,000 | 130,800.00 SEK |
| 2020-06-18 | Sven Rohmann | Other | Sell | 100,000 | 620,638.00 SEK |
| 2020-06-18 | Sven Rohmann | Other | Sell | 78,370 | 504,702.80 SEK |
Peer Companies
